87
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Mean Platelet Volume is Associated with Pancreatic β-Cell Dysfunction in Nondiabetic Patients with Coronary Artery Disease

, , , &
Pages 6359-6365 | Published online: 05 Oct 2021

References

  • Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets. 2002;13(5–6):301–306. doi:10.1080/095371002220148332
  • Pafili K, Penlioglou T, Mikhailidis DP, Papanas N. Mean platelet volume and coronary artery disease. Curr Opin Cardiol. 2019;34(4):390–398. doi:10.1097/HCO.0000000000000624
  • Machin SJ, Briggs C. Mean platelet volume: a quick, easy determinant of thrombotic risk? J Thromb Haemost. 2010;8(1):146–147. doi:10.1111/j.1538-7836.2009.03673.x
  • Varol E, Akcay S, Ozaydin M, Erdogan D, Dogan A, Altinbas A. Mean platelet volume is associated with insulin resistance in non-obese, non-diabetic patients with coronary artery disease. J Cardiol. 2010;56(2):154–158. doi:10.1016/j.jjcc.2010.03.005
  • Pizzulli L, Yang A, Martin JF, Lüderitz B. Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J. 1998;19(1):80–84. doi:10.1053/euhj.1997.0747
  • Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res. 2007;120(2):245–250. doi:10.1016/j.thromres.2006.10.005
  • Zaccardi F, Rocca B, Pitocco D, Tanese L, Rizzi A, Ghirlanda G. Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis. Diabetes Metab Res Rev. 2015;31(4):402–410. doi:10.1002/dmrr.2625
  • American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14–S31. doi:10.2337/dc20-S002
  • Baldane S, Ipekci SH, Kebapcilar A. Relationship between insulin resistance and mean platelet volume in gestational diabetes mellitus. J Lab Physicians. 2015;7(2):112–115. doi:10.4103/0974-2727.163134
  • Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–1495. doi:10.2337/diacare.27.6.1487
  • Wang T, Lu J, Shi L, et al. Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study. Lancet Diabetes Endocrinol. 2020;8(2):115–124. doi:10.1016/s2213-8587(19)30425-5
  • Sansanayudh N, Numthavaj P, Muntham D, et al. Prognostic effect of mean platelet volume in patients with coronary artery disease. A systematic review and meta-analysis. Thromb Haemost. 2015;114(6):1299–1309. doi:10.1160/th15-04-0280
  • Handtke S, Thiele T. Large and small platelets-(When) do they differ? J Thromb Haemost. 2020;18(6):1256–1267. doi:10.1111/jth.14788
  • Nozari Y, Parsa M, Jalali A, Ariannejad H, Shafiee A. Mean platelet volume and major adverse cardiac events following percutaneous coronary intervention. Arch Iran Med. 2019;22(4):198–203.
  • Hudish LI, Reusch JE, Sussel L. β cell dysfunction during progression of metabolic syndrome to type 2 diabetes. J Clin Invest. 2019;129(10):4001–4008. doi:10.1172/JCI129188
  • Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA. Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia. 2004;47(1):31–39. doi:10.1007/s00125-003-1263-9
  • Hunter RW, Hers I. Insulin/IGF-1 hybrid receptor expression on human platelets: consequences for the effect of insulin on platelet function. J Thromb Haemost. 2009;7(12):2123–2130. doi:10.1111/j.1538-7836.2009.03637.x
  • Kakouros N, Rade JJ, Kourliouros A, Resar JR. Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective. Int J Endocrinol. 2011;2011:742719. doi:10.1155/2011/742719
  • Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ. Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev. 1998;14(3):241–249. doi:10.1002/(sici)1099-0895(1998090)14:3<241::aid-dmr216>3.0.co;2-r
  • Keating FK, Sobel BE, Schneider DJ. Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus. Am J Cardiol. 2003;92(11):1362–1365. doi:10.1016/j.amjcard.2003.08.033
  • Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood. 2015;126(5):582–588. doi:10.1182/blood-2014-08-531582
  • Khodadi E. Platelet function in cardiovascular disease: activation of molecules and activation by molecules. Cardiovasc Toxicol. 2020;20(1):1–10. doi:10.1007/s12012-019-09555-4
  • Colkesen Y, Muderrisoglu H. The role of mean platelet volume in predicting thrombotic events. Clin Chem Lab Med. 2012;50(4):631–634. doi:10.1515/CCLM.2011.806
  • Guthikonda S, Alviar CL, Vaduganathan M, et al. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol. 2008;52(9):743–749. doi:10.1016/j.jacc.2008.05.031
  • Barale C, Russo I. Influence of cardiometabolic risk factors on platelet function. Int J Mol Sci. 2020;21(2):623. doi:10.3390/ijms21020623
  • Le Quellec S, Bordet JC, Negrier C, Dargaud Y. Comparison of current platelet functional tests for the assessment of aspirin and clopidogrel response. A review of the literature. Thromb Haemost. 2016;116(4):638–650. doi:10.1160/TH15-11-0870
  • Adjedj J, Xaplanteris P, Toth G, et al. Visual and quantitative assessment of coronary stenoses at angiography versus fractional flow reserve: the impact of risk factors. Circ Cardiovasc Imaging. 2017;10(7):e006243. doi:10.1161/circimaging.117.006243